Comments
The board of Vivimed Labs will meet on Monday to consider sub-division of its equity shares of face value ₹10 each into shares with lower face value. Traders and shareholders would be keen to know the ratio, as the stock has rallied to a high of ₹483 on Friday from ₹175 on June 2015. It currently hovers at around ₹475. Retail shareholders control 10.20 per cent stake in Vivimed. A stock split infuses liquidity into a stock, as it trades in a more affordable price range.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.